Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.20
-0.01 (-0.07%)
At close: Apr 22, 2026, 4:00 PM EDT
14.20
0.00 (0.00%)
After-hours: Apr 22, 2026, 4:10 PM EDT
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $2.19 billion as of April 22, 2026. Its market cap has increased by 97.00% in one year.
Market Cap
2.19B
Enterprise Value
2.13B
1-Year Change
97.00%
Ranking
Category
Stock Price
$14.20
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $2.19B, a decrease of -54.20%. That is a compound annual growth rate of -10.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 2.19B | -11.75% |
| Dec 31, 2025 | 2.48B | 180.23% |
| Dec 31, 2024 | 884.74M | 24.72% |
| Dec 29, 2023 | 709.39M | -35.07% |
| Dec 30, 2022 | 1.09B | -72.41% |
| Dec 31, 2021 | 3.96B | -51.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 2.42B |
| Definium Therapeutics | 2.31B |
| Sarepta Therapeutics | 2.25B |
| Day One Biopharmaceuticals | 2.22B |
| Trevi Therapeutics | 2.16B |
| Stoke Therapeutics | 2.16B |
| Mesoblast | 2.13B |
| Aurinia Pharmaceuticals | 2.12B |